Insider Transactions in Q2 2023 at Fate Therapeutics Inc (FATE)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2023
|
Yuan Xu |
SELL
Open market or private sale
|
Direct |
3,460
-25.83%
|
$17,300
$5.58 P/Share
|
|
Apr 21
2023
|
Redmile Group, LLC Director |
BUY
Open market or private purchase
|
Indirect |
256,639
+1.92%
|
$1,539,834
$6.18 P/Share
|
|
Apr 20
2023
|
Redmile Group, LLC Director |
BUY
Open market or private purchase
|
Indirect |
20,000
+0.16%
|
$100,000
$5.99 P/Share
|
|
Apr 18
2023
|
Yu Waye Chu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,532
-0.89%
|
$15,192
$6.55 P/Share
|
|
Apr 14
2023
|
Redmile Group, LLC Director |
BUY
Open market or private purchase
|
Indirect |
25,700
+0.2%
|
$154,200
$6.0 P/Share
|
|
Apr 14
2023
|
Redmile Group, LLC Director |
BUY
Other acquisition or disposition
|
Indirect |
5,492,385
+29.97%
|
$27,461,925
$5.84 P/Share
|
|
Apr 14
2023
|
Redmile Group, LLC Director |
SELL
Other acquisition or disposition
|
Indirect |
5,492,385
-29.97%
|
$27,461,925
$5.84 P/Share
|
|
Apr 14
2023
|
Redmile Group, LLC Director |
SELL
Open market or private sale
|
Indirect |
302,339
-2.3%
|
$1,511,695
$5.84 P/Share
|
|
Apr 13
2023
|
Redmile Group, LLC Director |
BUY
Conversion of derivative security
|
Indirect |
167,205
+1.26%
|
-
|